ArticleFrontiers in medicine2022

Case report: Sotrovimab, remdesivir and nirmatrelvir/ritonavir combination as salvage treatment option in two immunocompromised patients hospitalized for COVID-19.

Federico Baldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.